Peptide therapy, without the hype

Clinical protocols, member stories, and plain-language science from the Meto care team. We publish what we'd want to read if we were figuring this out for the first time

Featured

FDA Pharmacy Compounding Advisory Committee final peptide vote results, July 2026, six recommended one rejected

Hormones & Metabolism

FDA Peptide Decision 2026: The Final Vote on BPC-157, TB-500, MOTS-c and More — What It Means for You

Across July 23–24, 2026, the FDA's advisory committee recommended six peptides for legal compounding — BPC-157, KPV, TB-500, MOTS-c, epitalon, and Semax — and rejected one, emideltide (DSIP). Here's the complete scorecard, what it means, what it doesn't, and what to do next.

Editorial TeamJul 24, 20263 min read

Latest

Hormones & Metabolism
FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means
An FDA advisory committee voted on July 23, 2026 to recommend easing restrictions on four peptides — BPC-157, KPV, TB-500, and MOTS-c. Here's what that vote actually does, why it isn't an approval, and what it means for your health.
Dr. Jossy Onwude, MDJul 24, 20263 min read

Peptide therapy, without the hype

Featured

FDA Peptide Decision 2026: The Final Vote on BPC-157, TB-500, MOTS-c and More — What It Means for You

Latest

FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means

Peptide therapy, without the hype

Featured

FDA Peptide Decision 2026: The Final Vote on BPC-157, TB-500, MOTS-c and More — What It Means for You

Latest

FDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means

GLP-1 and Fertility: Emerging Evidence for Women With Obesity, Insulin Resistance, and PMOS

Ipamorelin: The Standalone Guide to the Most Selective Growth Hormone Peptide

Hexarelin: The Cardioprotective Growth Hormone Peptide That Mainstream Providers Overlook

GLP-1 and Thyroid Cancer Risk: What the Evidence Actually Says (and What It Doesn't)

The Exercise and Peptide Protocol: How to Get Maximum Results Combining Training With Therapy

Measuring Peptide Therapy Success: 12 Biomarkers That Matter More Than the Scale

Oxytocin: The Forgotten Metabolic Peptide and Its Role in Appetite, Obesity, and Emotional Eating

Peptide Therapy and Cancer: Addressing the Risks, the Evidence, and What Patients Should Know Before Starting

Peptides and Bone Health: What GH Peptides, GLP-1, and BPC-157 Mean for Osteoporosis Risk

Is Peptide Therapy Safe Long-Term? What 5+ Years of Clinical Data Tell Us

Using HSA and FSA Funds for Peptide Therapy: What Qualifies, How to Document It, and What to Avoid

Peptide Therapy and Drug Interactions: A Clinical Reference for Patients on Other Medications

VIP Peptide (Vasoactive Intestinal Peptide): Benefits, Mechanism, and What It Means for Gut and Inflammatory Health

Why You've Hit a Weight Loss Plateau on GLP-1: Root Causes and Peptide-Based Solutions

What Happens When You Stop Semaglutide: Weight Regain, Metabolic Reversal, and What the Science Says

Compounded vs Brand-Name Peptides: What You're Really Paying For (and What You're Risking)

GLP-1 and Sleep Apnea: What the Retatrutide TRIUMPH Data Means for Patients With Metabolic Sleep Disorders